nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—PTGIS—uterus—polycystic ovary syndrome	0.0136	0.104	CbGeAlD
Epoprostenol—PTGIS—adipose tissue—polycystic ovary syndrome	0.0133	0.101	CbGeAlD
Epoprostenol—CYP2C9—urine—polycystic ovary syndrome	0.0128	0.0975	CbGeAlD
Epoprostenol—Bimatoprost—PTGER3—polycystic ovary syndrome	0.0122	0.369	CrCbGaD
Epoprostenol—PTGIS—adrenal gland—polycystic ovary syndrome	0.0119	0.0909	CbGeAlD
Epoprostenol—PTGIS—female gonad—polycystic ovary syndrome	0.0111	0.0847	CbGeAlD
Epoprostenol—PTGIS—endocrine gland—polycystic ovary syndrome	0.0104	0.0788	CbGeAlD
Epoprostenol—PTGER1—female gonad—polycystic ovary syndrome	0.0104	0.0788	CbGeAlD
Epoprostenol—PTGER1—endocrine gland—polycystic ovary syndrome	0.00963	0.0732	CbGeAlD
Epoprostenol—P2RY12—endocrine gland—polycystic ovary syndrome	0.00933	0.0709	CbGeAlD
Epoprostenol—PTGIR—adipose tissue—polycystic ovary syndrome	0.00765	0.0582	CbGeAlD
Epoprostenol—Dinoprost Tromethamine—PTGER3—polycystic ovary syndrome	0.0074	0.223	CrCbGaD
Epoprostenol—PTGIR—adrenal gland—polycystic ovary syndrome	0.00686	0.0522	CbGeAlD
Epoprostenol—PTGIR—female gonad—polycystic ovary syndrome	0.0064	0.0487	CbGeAlD
Epoprostenol—PTGIR—endocrine gland—polycystic ovary syndrome	0.00595	0.0453	CbGeAlD
Epoprostenol—Dinoprostone—PTGER3—polycystic ovary syndrome	0.00569	0.172	CrCbGaD
Epoprostenol—Chest discomfort—Metformin—polycystic ovary syndrome	0.00519	0.0545	CcSEcCtD
Epoprostenol—Bimatoprost—AKR1C3—polycystic ovary syndrome	0.00513	0.155	CrCbGaD
Epoprostenol—Abdominal distension—Metformin—polycystic ovary syndrome	0.0029	0.0305	CcSEcCtD
Epoprostenol—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00276	0.029	CcSEcCtD
Epoprostenol—Infestation NOS—Metformin—polycystic ovary syndrome	0.00257	0.027	CcSEcCtD
Epoprostenol—Infestation—Metformin—polycystic ovary syndrome	0.00257	0.027	CcSEcCtD
Epoprostenol—Bradycardia—Metformin—polycystic ovary syndrome	0.00235	0.0247	CcSEcCtD
Epoprostenol—Rhinitis—Metformin—polycystic ovary syndrome	0.00231	0.0243	CcSEcCtD
Epoprostenol—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.0023	0.0241	CcSEcCtD
Epoprostenol—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00227	0.0239	CcSEcCtD
Epoprostenol—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00227	0.0238	CcSEcCtD
Epoprostenol—Flushing—Metformin—polycystic ovary syndrome	0.00214	0.0225	CcSEcCtD
Epoprostenol—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00214	0.0225	CcSEcCtD
Epoprostenol—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00213	0.0162	CbGeAlD
Epoprostenol—Angiopathy—Metformin—polycystic ovary syndrome	0.00209	0.022	CcSEcCtD
Epoprostenol—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00208	0.0218	CcSEcCtD
Epoprostenol—Chills—Metformin—polycystic ovary syndrome	0.00207	0.0217	CcSEcCtD
Epoprostenol—Flatulence—Metformin—polycystic ovary syndrome	0.00198	0.0208	CcSEcCtD
Epoprostenol—Muscle spasms—Metformin—polycystic ovary syndrome	0.00193	0.0203	CcSEcCtD
Epoprostenol—Tremor—Metformin—polycystic ovary syndrome	0.00188	0.0198	CcSEcCtD
Epoprostenol—Syncope—Metformin—polycystic ovary syndrome	0.0018	0.0189	CcSEcCtD
Epoprostenol—Palpitations—Metformin—polycystic ovary syndrome	0.00178	0.0186	CcSEcCtD
Epoprostenol—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00177	0.0185	CcSEcCtD
Epoprostenol—Dinoprostone—CYP11A1—polycystic ovary syndrome	0.00176	0.0532	CrCbGaD
Epoprostenol—Myalgia—Metformin—polycystic ovary syndrome	0.00171	0.018	CcSEcCtD
Epoprostenol—Chest pain—Metformin—polycystic ovary syndrome	0.00171	0.018	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.0017	0.0178	CcSEcCtD
Epoprostenol—Oedema—Metformin—polycystic ovary syndrome	0.00164	0.0172	CcSEcCtD
Epoprostenol—Infection—Metformin—polycystic ovary syndrome	0.00163	0.0171	CcSEcCtD
Epoprostenol—Shock—Metformin—polycystic ovary syndrome	0.00161	0.0169	CcSEcCtD
Epoprostenol—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00161	0.0169	CcSEcCtD
Epoprostenol—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00161	0.0169	CcSEcCtD
Epoprostenol—Skin disorder—Metformin—polycystic ovary syndrome	0.00159	0.0167	CcSEcCtD
Epoprostenol—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00158	0.0166	CcSEcCtD
Epoprostenol—Anorexia—Metformin—polycystic ovary syndrome	0.00156	0.0164	CcSEcCtD
Epoprostenol—Hypotension—Metformin—polycystic ovary syndrome	0.00153	0.0161	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00149	0.0157	CcSEcCtD
Epoprostenol—Paraesthesia—Metformin—polycystic ovary syndrome	0.00147	0.0155	CcSEcCtD
Epoprostenol—Dyspnoea—Metformin—polycystic ovary syndrome	0.00146	0.0154	CcSEcCtD
Epoprostenol—Somnolence—Metformin—polycystic ovary syndrome	0.00146	0.0153	CcSEcCtD
Epoprostenol—Dyspepsia—Metformin—polycystic ovary syndrome	0.00144	0.0152	CcSEcCtD
Epoprostenol—Decreased appetite—Metformin—polycystic ovary syndrome	0.00143	0.015	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00142	0.0149	CcSEcCtD
Epoprostenol—Fatigue—Metformin—polycystic ovary syndrome	0.00141	0.0148	CcSEcCtD
Epoprostenol—Constipation—Metformin—polycystic ovary syndrome	0.0014	0.0147	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00134	0.0141	CcSEcCtD
Epoprostenol—Urticaria—Metformin—polycystic ovary syndrome	0.0013	0.0137	CcSEcCtD
Epoprostenol—Abdominal pain—Metformin—polycystic ovary syndrome	0.0013	0.0136	CcSEcCtD
Epoprostenol—Asthenia—Metformin—polycystic ovary syndrome	0.00118	0.0124	CcSEcCtD
Epoprostenol—Pruritus—Metformin—polycystic ovary syndrome	0.00116	0.0122	CcSEcCtD
Epoprostenol—Diarrhoea—Metformin—polycystic ovary syndrome	0.00112	0.0118	CcSEcCtD
Epoprostenol—Dizziness—Metformin—polycystic ovary syndrome	0.00108	0.0114	CcSEcCtD
Epoprostenol—Vomiting—Metformin—polycystic ovary syndrome	0.00104	0.0109	CcSEcCtD
Epoprostenol—Rash—Metformin—polycystic ovary syndrome	0.00103	0.0109	CcSEcCtD
Epoprostenol—Dermatitis—Metformin—polycystic ovary syndrome	0.00103	0.0108	CcSEcCtD
Epoprostenol—Headache—Metformin—polycystic ovary syndrome	0.00103	0.0108	CcSEcCtD
Epoprostenol—Nausea—Metformin—polycystic ovary syndrome	0.000974	0.0102	CcSEcCtD
Epoprostenol—Dinoprostone—CYP19A1—polycystic ovary syndrome	0.00091	0.0275	CrCbGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000215	0.000291	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000214	0.000289	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000213	0.000288	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000213	0.000288	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—CYP11A1—polycystic ovary syndrome	0.000213	0.000287	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000211	0.000285	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000211	0.000285	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000208	0.00028	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000208	0.00028	CbGpPWpGaD
Epoprostenol—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000206	0.000279	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000206	0.000279	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000205	0.000277	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—TCF7L2—polycystic ovary syndrome	0.000202	0.000273	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000201	0.000271	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—AKR1C3—polycystic ovary syndrome	0.000201	0.000271	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—SLC2A4—polycystic ovary syndrome	0.000199	0.000268	CbGpPWpGaD
Epoprostenol—CYP2C9—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000198	0.000268	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000198	0.000268	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—CYP17A1—polycystic ovary syndrome	0.000198	0.000267	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000194	0.000262	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000194	0.000262	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000193	0.00026	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—POMC—polycystic ovary syndrome	0.00019	0.000256	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.00019	0.000256	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—PRL—polycystic ovary syndrome	0.00019	0.000256	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000188	0.000255	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000188	0.000255	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—FST—polycystic ovary syndrome	0.000188	0.000254	CbGpPWpGaD
Epoprostenol—CYP2C9—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000187	0.000253	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000187	0.000252	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000187	0.000252	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000185	0.000251	CbGpPWpGaD
Epoprostenol—CYP2C9—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000184	0.000249	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—LHB—polycystic ovary syndrome	0.000183	0.000248	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000182	0.000246	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000182	0.000246	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000179	0.000242	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—IGF1—polycystic ovary syndrome	0.000177	0.00024	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000177	0.00024	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000177	0.00024	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—AKT2—polycystic ovary syndrome	0.000177	0.000239	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000173	0.000234	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000173	0.000234	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FST—polycystic ovary syndrome	0.000173	0.000233	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—FST—polycystic ovary syndrome	0.000173	0.000233	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000172	0.000232	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000172	0.000232	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SCT—polycystic ovary syndrome	0.000172	0.000232	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—TH—polycystic ovary syndrome	0.000171	0.000231	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000171	0.000231	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000171	0.000231	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00017	0.00023	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00017	0.00023	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00017	0.000229	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—LHB—polycystic ovary syndrome	0.000169	0.000228	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000169	0.000228	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000168	0.000228	CbGpPWpGaD
Epoprostenol—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000167	0.000226	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—SLC2A4—polycystic ovary syndrome	0.000166	0.000225	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000165	0.000223	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000165	0.000223	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000164	0.000221	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—IGF1—polycystic ovary syndrome	0.000163	0.000221	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—AKT2—polycystic ovary syndrome	0.000163	0.00022	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000161	0.000217	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00016	0.000216	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00016	0.000216	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00016	0.000216	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000159	0.000215	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000159	0.000215	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—NCOR1—polycystic ovary syndrome	0.000159	0.000215	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SCT—polycystic ovary syndrome	0.000158	0.000213	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000158	0.000213	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000157	0.000212	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—CYP19A1—polycystic ovary syndrome	0.000156	0.000211	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000156	0.000211	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000156	0.000211	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—NRG1—polycystic ovary syndrome	0.000156	0.000211	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000155	0.000209	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000151	0.000204	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000151	0.000204	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000149	0.000201	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000148	0.0002	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000148	0.0002	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000148	0.0002	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000147	0.000199	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000147	0.000198	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000147	0.000198	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000146	0.000198	CbGpPWpGaD
Epoprostenol—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000146	0.000197	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000145	0.000195	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000145	0.000195	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000143	0.000193	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—INSR—polycystic ovary syndrome	0.000141	0.00019	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—MTHFR—polycystic ovary syndrome	0.00014	0.00019	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—GNAS—polycystic ovary syndrome	0.00014	0.000189	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000137	0.000185	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000137	0.000185	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000135	0.000183	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000135	0.000183	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000135	0.000183	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000134	0.00018	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—IRS2—polycystic ovary syndrome	0.000134	0.00018	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—NCOR1—polycystic ovary syndrome	0.000133	0.00018	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000131	0.000178	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PGR—polycystic ovary syndrome	0.00013	0.000176	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000129	0.000175	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—INSR—polycystic ovary syndrome	0.000129	0.000175	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000129	0.000174	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—CYP1A1—polycystic ovary syndrome	0.000126	0.00017	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000123	0.000166	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000123	0.000166	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000121	0.000163	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000121	0.000163	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000121	0.000163	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000121	0.000163	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PGR—polycystic ovary syndrome	0.00012	0.000162	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PGR—polycystic ovary syndrome	0.00012	0.000162	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000119	0.000161	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—MTHFR—polycystic ovary syndrome	0.000118	0.000159	CbGpPWpGaD
Epoprostenol—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000118	0.000159	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—IRS1—polycystic ovary syndrome	0.000117	0.000157	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000117	0.000157	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—VEGFA—polycystic ovary syndrome	0.000116	0.000157	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000115	0.000156	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000113	0.000152	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000112	0.000151	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—INS—polycystic ovary syndrome	0.000112	0.000151	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000111	0.00015	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000111	0.00015	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000111	0.00015	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000111	0.00015	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00011	0.000148	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—AKT2—polycystic ovary syndrome	0.000108	0.000146	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000107	0.000145	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000107	0.000145	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—VEGFA—polycystic ovary syndrome	0.000107	0.000144	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000107	0.000144	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000106	0.000143	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000106	0.000143	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000106	0.000143	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PRL—polycystic ovary syndrome	0.000106	0.000143	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.000105	0.000142	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000104	0.00014	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000104	0.00014	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000103	0.000139	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000103	0.000139	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—SERPINE1—polycystic ovary syndrome	0.000103	0.000139	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000102	0.000137	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.0001	0.000135	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.0001	0.000135	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NGFR—polycystic ovary syndrome	9.8e-05	0.000132	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NGFR—polycystic ovary syndrome	9.8e-05	0.000132	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	9.77e-05	0.000132	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—POMC—polycystic ovary syndrome	9.74e-05	0.000132	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—POMC—polycystic ovary syndrome	9.74e-05	0.000132	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PRL—polycystic ovary syndrome	9.71e-05	0.000131	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PRL—polycystic ovary syndrome	9.71e-05	0.000131	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	9.59e-05	0.000129	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	9.59e-05	0.000129	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PPARG—polycystic ovary syndrome	9.53e-05	0.000129	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	9.46e-05	0.000128	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—POMC—polycystic ovary syndrome	9.4e-05	0.000127	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.36e-05	0.000126	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.36e-05	0.000126	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—INS—polycystic ovary syndrome	9.35e-05	0.000126	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—GNAS—polycystic ovary syndrome	9.29e-05	0.000125	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.22e-05	0.000125	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.22e-05	0.000125	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	8.91e-05	0.00012	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	8.88e-05	0.00012	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.85e-05	0.00012	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	8.71e-05	0.000118	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NRG1—polycystic ovary syndrome	8.68e-05	0.000117	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—GNAS—polycystic ovary syndrome	8.55e-05	0.000115	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—GNAS—polycystic ovary syndrome	8.55e-05	0.000115	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.14e-05	0.00011	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.14e-05	0.00011	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	8.13e-05	0.00011	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NRG1—polycystic ovary syndrome	7.99e-05	0.000108	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NRG1—polycystic ovary syndrome	7.99e-05	0.000108	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	7.71e-05	0.000104	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	7.58e-05	0.000102	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	7.58e-05	0.000102	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IRS2—polycystic ovary syndrome	7.44e-05	0.0001	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	7.29e-05	9.84e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—LEP—polycystic ovary syndrome	7.28e-05	9.83e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	7.17e-05	9.69e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IRS2—polycystic ovary syndrome	6.84e-05	9.25e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IRS2—polycystic ovary syndrome	6.84e-05	9.25e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—LEP—polycystic ovary syndrome	6.7e-05	9.05e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—LEP—polycystic ovary syndrome	6.7e-05	9.05e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IRS1—polycystic ovary syndrome	6.49e-05	8.77e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	6.35e-05	8.58e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—POMC—polycystic ovary syndrome	6.25e-05	8.45e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—INS—polycystic ovary syndrome	6.22e-05	8.4e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	6.02e-05	8.13e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IGF1—polycystic ovary syndrome	6.01e-05	8.12e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—AKT2—polycystic ovary syndrome	6.01e-05	8.12e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IRS1—polycystic ovary syndrome	5.98e-05	8.07e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IRS1—polycystic ovary syndrome	5.98e-05	8.07e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—POMC—polycystic ovary syndrome	5.75e-05	7.77e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—POMC—polycystic ovary syndrome	5.75e-05	7.77e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	5.74e-05	7.76e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—INS—polycystic ovary syndrome	5.72e-05	7.73e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—INS—polycystic ovary syndrome	5.72e-05	7.73e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.71e-05	7.72e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	5.68e-05	7.67e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IGF1—polycystic ovary syndrome	5.53e-05	7.48e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IGF1—polycystic ovary syndrome	5.53e-05	7.48e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—AKT2—polycystic ovary syndrome	5.53e-05	7.47e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—AKT2—polycystic ovary syndrome	5.53e-05	7.47e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.26e-05	7.1e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.26e-05	7.1e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	5.12e-05	6.91e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	4.88e-05	6.6e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—IL6—polycystic ovary syndrome	4.88e-05	6.59e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	4.83e-05	6.52e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL6—polycystic ovary syndrome	4.6e-05	6.21e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	4.58e-05	6.18e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	4.45e-05	6.02e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	4.35e-05	5.88e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL6—polycystic ovary syndrome	4.23e-05	5.72e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL6—polycystic ovary syndrome	4.23e-05	5.72e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	4.21e-05	5.69e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.93e-05	5.31e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	3.88e-05	5.24e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	3.76e-05	5.07e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	3.62e-05	4.89e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.62e-05	4.88e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.62e-05	4.88e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	3.48e-05	4.7e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.46e-05	4.67e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	3.44e-05	4.64e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.41e-05	4.61e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	3.24e-05	4.38e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	3.19e-05	4.32e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—TH—polycystic ovary syndrome	2.76e-05	3.73e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL6—polycystic ovary syndrome	2.72e-05	3.67e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	2.69e-05	3.63e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	2.53e-05	3.41e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL6—polycystic ovary syndrome	2.5e-05	3.38e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL6—polycystic ovary syndrome	2.5e-05	3.38e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	2.26e-05	3.05e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	2.15e-05	2.9e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	2.04e-05	2.75e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	1.9e-05	2.57e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	1.54e-05	2.08e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	1.52e-05	2.05e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—INS—polycystic ovary syndrome	1.51e-05	2.04e-05	CbGpPWpGaD
